Author:
Diaz-Gil Daniel,Carreon Chrystalle Katte,Silva-Gomez Natalia,Benheim Alan E.,Emani Sitaram M.,del Nido Pedro J.,Marx Gerald R.,Friehs Ingeborg
Abstract
This is the first description of active clinical manifestation of endocardial fibroelastosis (EFE) and remodeling of the endocardium via endothelial-to-mesenchymal transformation (EndMT) in an adolescent with Shone’s variant hypoplastic left heart complex (HLHC) and a genetic heterozygous ABL1 variant. While EFE has not been typically associated HLHC or Shone’s syndrome, in this patient flow alterations in the left ventricle (LV), combined with genetic alterations of intrinsic EndMT pathways led to active clinical manifestation of EFE in adolescence. This case emphasizes that new therapies for EFE might need to focus on molecular factors influenced by intrinsic and extrinsic stimuli of EndMT.
Subject
Cardiology and Cardiovascular Medicine
Reference26 articles.
1. The developmental complex of “parachute mitral valve,” supravalvular ring of left atrium, subaortic stenosis, and coarctation of aorta.;Shone;Am J Cardiol.,1963
2. Biventricular repair in neonates with hypoplastic left heart complex.;Tchervenkov;Ann Thorac Surg.,1998
3. The incidence of congenital heart disease.;Hoffman;J Am Coll Cardiol.,2002
4. Fetal and perinatal cardiology.;Shaddy;Moss & adams’ heart disease in infants, children, and adolescents.,2013
5. Flow disturbances and the development of endocardial fibroelastosis.;Weixler;J Thor Cardiovasc Surg.,2020